As of Friday, December 26, Sol-Gel Technologies Ltd.’s SLGL share price has dipped by 5.05%, which has investors questioning if this is right time to buy.

NESS ZIONA, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended ...

Sol-gel manufacturing can be used to create various high-performance solids including glasses and ceramics. In the field of glass production, sol-gel techniques are a reliable low-temperature ...

Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...

Shares of Sol-Gel Technologies (SLGL) were in the spotlight on Friday morning after the company’s first-quarter (Q1) revenue dipped below Wall Street expectations, and losses came in ...

Just because a business does not make any money, does not mean that the stock will go down. For example, Sol-Gel Technologies (NASDAQ:SLGL) shareholders have done very well over the last year, with ...

Sol-Gel Technologies (SLGL) fell ~10% in the premarket on Wednesday after the dermatological drug developer announced that unfavorable data from an early-stage trial had prompted it to halt further ...

NESS ZIONA, Israel & LAUSANNE, Switzerland--(BUSINESS WIRE)--Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world’s largest independent dermatology ...

SLGL is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of SLGL shares has increased $0.79 since the market last closed. This is a 1.79% ...